Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The Journal of Infectious Diseases|March 24, 2020
Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S SubstudyAshwin Balagopal, Laura M Smeaton, Jeffrey Quinn, et al.
Clinical and Translational Science|January 27, 2026
Enhanced Clearance of HIV-1 Broadly Neutralizing Antibody VRC07-523-LS During Viremia: Influences on Trial Design and AnalysisNicholas M Smith, Brian M Ho, Katharine J Bar, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Eleven Years of Change: Disease Progression in Biomarker-Defined Sporadic Parkinson's DiseasePaulina Gonzalez-Latapi, Caroline Gochanour, Hyunkeun Cho, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 6, 2015
Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantationIan A Rowe, Damien C Tully, Matthew J Armstrong, et al.
Annals of Clinical and Translational Neurology|March 11, 2026
Five-Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's DiseasePaulina Gonzalez-Latapi, Caroline Gochanour, Seung Ho Choi, et al.
Annals of Neurology|May 19, 2026
Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers InitiativePaulina Gonzalez-Latapi, Caroline Gochanour, Seung Ho Choi, et al.
PLOS Digital Health|March 28, 2023
Developing better digital health measures of Parkinson's disease using free living data and a crowdsourced data analysis challengeSolveig K Sieberts, Henryk Borzymowski, Yuanfang Guan, et al.
Clinical Pharmacology and Therapeutics|April 24, 2021
A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine-Rich Repeat Kinase 2 MutationMalidi Ahamadi, Nitin Mehrotra, Nathan Hanan, et al.
Brain Communications|March 21, 2025
LRRK2-associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterizationLana M Chahine, David-Erick Lafontant, Seung Ho Choi, et al.
Medrxiv : the Preprint Server for Health Sciences|August 7, 2024
LRRK2-Associated Parkinsonism With and Without In Vivo Evidence of Alpha-Synuclein AggregatesLana M Chahine, David-Erick Lafontant, Seung Ho Choi, et al.
Pageof 4